Al-Razi Medical Co.

Saudi Stock Exchange 9572.SR

Al-Razi Medical Co. EBITDA for the year ending December 31, 2023: USD 1.35 M

Al-Razi Medical Co. EBITDA is USD 1.35 M for the year ending December 31, 2023, a -11.21% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Al-Razi Medical Co. EBITDA for the year ending December 31, 2022 was USD 1.52 M, a 11.56% change year over year.
  • Al-Razi Medical Co. EBITDA for the year ending December 31, 2021 was USD 1.36 M.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
SV Wall Street
Saudi Stock Exchange: 9572.SR

Al-Razi Medical Co.

CEO Hussain Osman Hussain Al-Alawi
IPO Date June 22, 2023
Location Saudi Arabia
Headquarters Hajar Commercial Center
Employees 123
Sector Healthcare
Industries
Hospitals & Clinics Drugstores & Retail Pharmacies Medical Instruments Telehealth
Description

Al-Razi Medical Company supplies medical equipment in Saudi Arabia. The company sells hospital beds, steam and suction devices, inhalation devices, masks, needles, oxygen masks, water bladders, bandages, gloves, and ear piercings. It serves hospitals, clinics, medical centers, medical companies, and pharmacies. The company was founded in 1986 and is headquartered in Dammam, Saudi Arabia.

StockViz Staff

February 11, 2025

Any question? Send us an email